These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration. Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139 [TBL] [Abstract][Full Text] [Related]
23. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution. Avram MJ; Krejcie TC; Henthorn TK; Niemann CU J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245 [TBL] [Abstract][Full Text] [Related]
24. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462 [TBL] [Abstract][Full Text] [Related]
25. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782 [TBL] [Abstract][Full Text] [Related]
26. Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. Pitzalis MV; Mastropasqua F; Massari F; Passantino A; Totaro P; Forleo C; Rizzon P Chest; 1998 Jul; 114(1):185-91. PubMed ID: 9674468 [TBL] [Abstract][Full Text] [Related]
27. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition. Bax ND; Tucker GT; Lennard MS; Woods HF Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914 [TBL] [Abstract][Full Text] [Related]
28. Metoprolol or propranolol does not alter the kinetics of procainamide. Ochs HR; Carstens G; Roberts GM; Greenblatt DJ J Cardiovasc Pharmacol; 1983; 5(3):392-5. PubMed ID: 6191137 [TBL] [Abstract][Full Text] [Related]
29. Lidocaine elimination: effects of metoprolol and of propranolol. Conrad KA; Byers JM; Finley PR; Burnham L Clin Pharmacol Ther; 1983 Feb; 33(2):133-8. PubMed ID: 6822025 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist. Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722 [TBL] [Abstract][Full Text] [Related]
31. Physiological and pharmacological variability in estimated hepatic blood flow in man. Daneshmend TK; Jackson L; Roberts CJ Br J Clin Pharmacol; 1981 May; 11(5):491-6. PubMed ID: 6115663 [TBL] [Abstract][Full Text] [Related]
32. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man. Thomas MS; Tattersfield AE Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056 [TBL] [Abstract][Full Text] [Related]
33. Selective and nonselective beta-blockade of the peripheral circulation. Hiatt WR; Fradl DC; Zerbe GO; Byyny RL; Nies AS Clin Pharmacol Ther; 1984 Jan; 35(1):12-8. PubMed ID: 6690167 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure. Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876 [TBL] [Abstract][Full Text] [Related]
35. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate). Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871 [TBL] [Abstract][Full Text] [Related]
36. Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome. Besana A; Wang DW; George AL; Schwartz PJ J Cardiovasc Pharmacol; 2012 Mar; 59(3):249-53. PubMed ID: 22030895 [TBL] [Abstract][Full Text] [Related]
37. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance. Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012 [TBL] [Abstract][Full Text] [Related]
38. Effects of acute cardioselective and non-selective beta-adrenergic blockade on left-ventricular volumes and vascular resistance at rest and during exercise. Kelbaek H; Godtrfedsen J Scand J Clin Lab Invest; 1991 Apr; 51(2):161-6. PubMed ID: 1675022 [TBL] [Abstract][Full Text] [Related]
39. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis. Merkel C; Sacerdoti D; Bolognesi M; Buonamico P; Sticca A; Amodio P; Angeli P; Micotti L; Gatta A Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530 [TBL] [Abstract][Full Text] [Related]
40. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog. Ono H; Kanazawa Y; O'Hara N; Hashimoto K Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]